+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Biomarkers Market by Biomarker Type (Genetic, Imaging, Metabolite), Disease Indication (Alzheimer's Disease, Epilepsy, Multiple Sclerosis), Sample Type, Technology, End User - Global Forecast 2025-2030- Product Image
Brain Biomarkers Market by Biomarker Type (Genetic, Imaging, Metabolite), Disease Indication (Alzheimer's Disease, Epilepsy, Multiple Sclerosis), Sample Type, Technology, End User - Global Forecast 2025-2030- Product Image
Sale

Brain Biomarkers Market by Biomarker Type (Genetic, Imaging, Metabolite), Disease Indication (Alzheimer's Disease, Epilepsy, Multiple Sclerosis), Sample Type, Technology, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011102
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain biomarkers market is experiencing significant growth, driven by the urgent need for precision tools that can advance neurodegenerative disease diagnosis and management. Rising demand for early detection, patient monitoring, and personalized treatment strategies further accelerates market innovation and adoption.

Market Snapshot: Brain Biomarkers Market Size and Outlook

The Brain Biomarkers Market grew from USD 10.54 billion in 2024 to USD 12.50 billion in 2025. It is expected to continue growing at a CAGR of 17.95%, reaching USD 28.39 billion by 2030. Expansion is underpinned by enhanced molecular diagnostics, AI-driven analytics, and prioritization of early detection solutions across neurological care and research sectors.

Scope & Segmentation of the Brain Biomarkers Market

This report provides a comprehensive overview of the complex landscape of brain biomarkers, highlighting critical segmentation points across multiple axes of market activity.

  • Biomarker Type: Genetic (including gene expression, miRNA, SNP markers), imaging (CT, MRI, PET), metabolite (lipid, small molecule), and protein (CSF, plasma, saliva proteins).
  • Disease Indication: Alzheimer’s disease, epilepsy, multiple sclerosis, Parkinson’s disease, and stroke, showcasing the diverse clinical applications of biomarker technologies.
  • Sample Type: Blood (plasma, serum), cerebrospinal fluid, saliva, and urine, offering multiple platforms for both invasive and non-invasive biomarker assessments.
  • Technology: Chromatography (HPLC, UHPLC), immunoassays (ELISA, lateral flow), mass spectrometry (GC-MS, LC-MS), next-generation sequencing (targeted, whole genome), and PCR methods (digital, qPCR).
  • End User: Contract research organizations, diagnostic laboratories, hospitals, pharmaceutical companies, and research institutes, reflecting the market’s depth and breadth across the healthcare and research ecosystem.
  • Regional Coverage: Americas (including key U.S. states), Europe, Middle East & Africa (notably the U.K., Germany, France, and leading GCC countries), and Asia-Pacific (featuring China, India, Japan, and other economies driving innovation and production capacity).
  • Key Companies: F. Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Danaher, Abbott, Bio-Rad, Quanterix, Fujirebio, PerkinElmer, and Bio-Techne.

Key Takeaways for Senior Decision-Makers

  • Technological advances, such as multi-omics integration with AI analytics, are rapidly reshaping how brain biomarkers are discovered, validated, and deployed for clinical and research use.
  • Strategic partnerships between academic institutions, industry, and healthcare systems are fast-tracking translational research and facilitating streamlined regulatory pathways for new biomarker adoption.
  • Regulatory bodies are adapting to support innovative clinical trial designs and real-world evidence, making the path to clinical adoption for brain biomarkers increasingly efficient.
  • Market segmentation reveals differentiated needs, with blood and non-invasive samples improving access to screening, while advanced protein and genetic markers drive specificity in disease monitoring.
  • Competition is intensifying as leading companies leverage acquisitions, platform scalability, and open-source architectures to improve interoperability and support evolving biomarker portfolios.
  • Growth is reinforced by increased investment in regional manufacturing and localization strategies, particularly in response to evolving trade policies and supply chain adjustments.

Tariff Impact: Supply Chain and Manufacturing Adaptations

Recent U.S. tariff adjustments have impacted supply chains for brain biomarker research. Import duties on reagents and instruments are prompting organizations to restructure procurement and explore domestic manufacturing. Larger enterprises are partnering with regional producers, while smaller players increasingly pursue consortium-based purchasing and shared resource models to remain competitive. These developments may lead to more resilient supply networks but place added pressure on budget-limited organizations, highlighting the need for ongoing stakeholder engagement and policy advocacy.

Methodology & Data Sources

This report leverages primary research, including in-depth expert interviews from neurology, diagnostics, and bioinformatics, alongside secondary research across peer-reviewed publications, regulatory documents, and commercial data. Triangulation and quality controls ensure that all findings are robust and actionable for executive decision-making.

Why This Report Matters: Benefits for Decision-Makers

  • Informed strategic planning is enabled by a complete landscape view, identifying investment opportunities and operational risks linked to evolving diagnostic, regulatory, and market trends.
  • Senior leaders can optimize R&D and market entry by understanding how technology, policy, and regional shifts intersect in brain biomarker adoption and commercialization.

Conclusion

The brain biomarkers market is poised for sustained growth with increasing clinical reliance on innovative, data-driven diagnostics. Senior decision-makers can leverage these insights to guide investments, policy, and operational strategies for lasting competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multiomics data with machine learning for precision brain biomarker profiling in Alzheimer’s disease
5.2. Commercialization of ultra-sensitive immunoassays enabling early detection of Parkinson’s disease pathology from plasma samples
5.3. Development of digital biomarker platforms using wearable EEG and neuroimaging for real-time cognitive monitoring
5.4. Standardization initiatives for cerebrospinal fluid tau and amyloid beta quantification across global clinical laboratories
5.5. Growth of companion diagnostic biomarker tests for targeted therapies in multiple sclerosis and glioblastoma treatment protocols
5.6. Utilization of exosomal microRNA signatures in blood as non-invasive indicators of traumatic brain injury severity and prognosis
5.7. Expansion of point-of-care biomarker testing devices for rapid stroke subtype differentiation in emergency care settings
5.8. Integration of AI-driven image analysis to quantify PET-based neuroinflammation biomarkers in clinical trials
5.9. Emergence of normative brain network connectivity metrics as predictive biomarkers for psychiatric disorder onset and progression
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brain Biomarkers Market, by Biomarker Type
8.1. Introduction
8.2. Genetic
8.2.1. Gene Expression Markers
8.2.2. Mirna Markers
8.2.3. Snp Markers
8.3. Imaging
8.3.1. Ct
8.3.2. Mri
8.3.3. Pet
8.4. Metabolite
8.4.1. Lipid Metabolites
8.4.2. Small Molecule Metabolites
8.5. Protein
8.5.1. Csf Proteins
8.5.2. Plasma Proteins
8.5.3. Saliva Proteins
9. Brain Biomarkers Market, by Disease Indication
9.1. Introduction
9.2. Alzheimer's Disease
9.3. Epilepsy
9.4. Multiple Sclerosis
9.5. Parkinson's Disease
9.6. Stroke
10. Brain Biomarkers Market, by Sample Type
10.1. Introduction
10.2. Blood
10.2.1. Plasma
10.2.2. Serum
10.3. Cerebrospinal Fluid
10.4. Saliva
10.5. Urine
11. Brain Biomarkers Market, by Technology
11.1. Introduction
11.2. Chromatography
11.2.1. Hplc
11.2.2. Uhplc
11.3. Immunoassay
11.3.1. Elisa
11.3.2. Lateral Flow Assay
11.4. Mass Spectrometry
11.4.1. Gc-ms
11.4.2. Lc-ms
11.5. Next Generation Sequencing
11.5.1. Targeted Sequencing
11.5.2. Whole Genome Sequencing
11.6. Pcr
11.6.1. Digital Pcr
11.6.2. Qpcr
12. Brain Biomarkers Market, by End User
12.1. Introduction
12.2. Contract Research Organizations
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Pharmaceutical Companies
12.6. Research Institutes
13. Americas Brain Biomarkers Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Brain Biomarkers Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Brain Biomarkers Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Siemens Healthineers AG
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Danaher Corporation
16.3.5. Abbott Laboratories
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Quanterix Corporation
16.3.8. Fujirebio Holdings, Inc.
16.3.9. PerkinElmer, Inc.
16.3.10. Bio-Techne Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRAIN BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRAIN BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRAIN BIOMARKERS MARKET: RESEARCHAI
FIGURE 26. BRAIN BIOMARKERS MARKET: RESEARCHSTATISTICS
FIGURE 27. BRAIN BIOMARKERS MARKET: RESEARCHCONTACTS
FIGURE 28. BRAIN BIOMARKERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRAIN BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENE EXPRESSION MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENE EXPRESSION MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MIRNA MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MIRNA MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SNP MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SNP MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LIPID METABOLITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LIPID METABOLITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SMALL MOLECULE METABOLITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SMALL MOLECULE METABOLITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CSF PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CSF PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HPLC, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HPLC, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY UHPLC, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY UHPLC, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 195. CANADA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 196. CANADA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 197. CANADA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 198. CANADA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 199. CANADA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 200. CANADA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 201. CANADA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 202. CANADA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 203. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 204. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 205. CANADA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 206. CANADA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 207. CANADA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 208. CANADA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 209. CANADA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 210. CANADA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 211. CANADA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. CANADA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. CANADA BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 214. CANADA BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 215. CANADA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 216. CANADA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 217. CANADA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 218. CANADA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 219. CANADA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 220. CANADA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 221. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 222. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 223. CANADA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. CANADA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 246. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 247. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 248. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 249. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 250. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 251. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 252. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 348. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2024 (USD MILLION)
TABLE 350. UNITED

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Quanterix Corporation
  • Fujirebio Holdings, Inc.
  • PerkinElmer, Inc.
  • Bio-Techne Corporation

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 12.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 28.39 Billion
Compound Annual Growth Rate17.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Traumatic Brain Injury Biomarkers Market Size, Share & Trends Analysis Report By Type (Protein Biomarkers, Genetic Biomarkers), By Sample Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Traumatic Brain Injury Biomarkers Market Size, Share & Trends Analysis Report By Type (Protein Biomarkers, Genetic Biomarkers), By Sample Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Central Nervous System Biomarkers Market by Type (Genomic Biomarkers, Metabolomic Biomarkers, Proteomic Biomarkers), Disease Indication (Neurodegenerative Diseases, Neurodevelopmental Disorders, Psychotic Disorders), Technology, Application, End-User - Global Forecast 2025-2030 - Product Image

Central Nervous System Biomarkers Market by Type (Genomic Biomarkers, Metabolomic Biomarkers, Proteomic Biomarkers), Disease Indication (Neurodegenerative Diseases, Neurodevelopmental Disorders, Psychotic Disorders), Technology, Application, End-User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Cardiac Biomarkers Market Report by Type, Location of Testing, Application, and Region 2025-2033 - Product Image

Cardiac Biomarkers Market Report by Type, Location of Testing, Application, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Cardiac Biomarkers - Global Strategic Business Report - Product Image

Cardiac Biomarkers - Global Strategic Business Report

  • Report
  • 272 Pages
  • Global
From

About the Market

A neurological biomarker is a biological indicator of a neurological disorder or disease. It is used to diagnose, monitor, and predict the progression of neurological diseases. Neurological biomarkers can be found in a variety of biological samples, such as blood, cerebrospinal fluid, and tissue. They can also be used to measure the effectiveness of treatments. Neurological biomarkers are becoming increasingly important in the field of personalized medicine, as they can provide a more accurate diagnosis and prognosis of neurological diseases. They can also be used to identify potential drug targets and to monitor the progression of neurological diseases. The neurological biomarker market is growing rapidly, driven by the increasing prevalence of neurological diseases, the development of new technologies, and the increasing demand for personalized medicine. The market is expected to continue to grow in the coming years, as more companies enter the market and develop new technologies. Some of the major companies in the neurological biomarker market include Bio-Rad Laboratories, Inc., BioMérieux SA, Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.